Published in Medical Letter on the CDC and FDA, December 14th, 2003
This product line features a proprietary covering to prevent tissue ingrowth into the defibrillation coils without compromising the electrical performance of the lead. According to the company, it is the first defibrillation lead on the market to address tissue ingrowth using this approach. Preventing tissue ingrowth assists physicians with long-term management of implantable cardioverter defibrillator (ICD) patients.
Defibrillation leads are thin, insulated wires that connect an implantable defibrillator to the heart....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA